NRAS and melanoma: Previous studies have identified several molecular drivers of melanoma that affect aerobic glycolysis and OXPHOS, as well as the expression levels of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α), BRAF, and NRAS.